Orally administered L-ornithine elevates brain L-ornithine levels and has an anxiolytic-like effect in mice

Nutritional Neuroscience

Volumn 14, Issue 6, 2011, Pages 243-248

  Kurata, Koji ^a   Nagasawa, Mao ^a   Tomonaga, Shozo ^a   Aoki, Mami ^b   Morishita, Koji ^b   Denbow, D Michael ^c   Furuse, Mitsuhiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Kyowa Hakko Bio Co Ltd   (Japan)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Amino acids; Anxiety; L ornithine; Oral administration; Stress

Indexed keywords

ARGININE; CITRULLINE; LYSINE; ORNITHINE;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ANXIETY DISORDER; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; EXPERIMENTAL MOUSE; HIPPOCAMPUS; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ARGININE; BEHAVIOR, ANIMAL; BRAIN; CEREBRAL CORTEX; CITRULLINE; DIETARY SUPPLEMENTS; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; MALE; MICE; MICE, INBRED ICR; ORNITHINE; STRESS, PSYCHOLOGICAL; TIME FACTORS;

MUS; RODENTIA;

EID: 81255195520     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830511Y.0000000018     Document Type: Article

References (24)

1. Leonard BE. Stress, norepinephrine and depression. J Psychiatry Neurosci 2001;26:11-6.
2. Fone KCF, Porkess MV. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neurosci Biobehav Rev 2008; 32:1087-102.
3. Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J 1998;336:1-17.
4. Morris SM, Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002;22:87-105.
5. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982;243:C212-21.
6. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem 1984;53: 749-90.
7. Suenaga R, Yamane H, Tomonaga S, Asechi M, Adachi N, Tsuneyoshi Y, et al. Central L-arginine reduced stress responses are mediated by L-ornithine in neonatal chicks. Amino Acids 2008;35:107-13.
8. Hamasu K, Haraguchi T, Kabuki Y, Adachi N, Tomonaga S, Sato H, et al. L-proline is a sedative regulator of acute stress in the brain of neonatal chicks. Amino Acids 2009;37:377-82.
9. Suenaga R, Tomonaga S, Yamane H, Kurauchi I, Tsuneyoshi Y, Sato H, et al. Intracerebroventricular injection of L-arginine induces sedative and hypnotic effects under an acute stress in neonatal chicks. Amino Acids 2008;35:139-46.
10. Kurauchi I, Shigemi K, Kabuki Y, Hamasu K, Yamane H, Aoki M, et al. Central L-ornithine, but not polyamines, induces a hypnotic effect in neonatal chicks under acute stress. Nutr Neurosci 2010;13:17-20.
11. Kurauchi I, Shigemi K, Yamada S, Aoki M, Kawada Y, Morishita K, et al. Comparison of central effects of L-ornithine metabolites on the stress responses of neonatal chicks. J Anim Vet Adv 2009;8:2580-4.
12. Komada M, Takao K, Miyakawa T. Elevated plus maze for mice [Video article]. J Vis Exp 2008;22. Available from: http://www.jove.com/index/details.stp?id=1088.
13. Pellow S, Chopin P, File SE, Briley M. Validation of open, close arm entries in an elevated plus-maze as a measurement of anxiety in the rat. J Neurosci Methods 1985;14:149-67.
14. Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plusmaze. Neurosci Biobehav Rev. 1997;21:801-10.
15. Kurata K, Shigemi K, Tomonaga S, Aoki M, Morishita K, Denbow DM, et al. L-Ornithine attenuates corticotropin-releasing factor-induced stress responses acting at GABA-A receptors in neonatal chicks. Neuroscience 2011;172:226-31.
16. Ohtsuki S, Terasaki T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res 2007;24:1745-58.
17. O'Kane RL, Vina JR, Simpson I, Zaragoza R, Mokashi A, Hawkins RA. Cationic amino acid transport across the bloodbrain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab 2006;291:412-9.
18. Rocha JC, Martel F. Large neutral amino acids supplementation in phenylketonuric patients. J Inherit Metab Dis 2009;32:472-80.
19. Igarashi K, Sugiyama Y, Kasuya F, Inoue H, Matoba R, Castagnoli N. Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 2000;746:33-40.
20. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 1991;88:2811-4.
21. Zomkowski ADE, Santos ARS, Rodrigues ALS. Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1419-25.
22. Korte SM, Boer SF. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 2003;463:163-75.
23. Rabow LE, Russek SJ, Farb DH. From ion currents to genomic analysis: recent advances in GABAA receptor research. Synapse 1995;21:189-274.
24. Sieghart W. Structure and pharmacology of gamma-aminobutyric acid A receptor subtypes. Pharmacol Rev 1995;47:181-234